Original paper
Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World
Volume: 25, Issue: 6, Pages: 697 - 704
Published: Jun 1, 2019
Abstract
BACKGROUND: The treatment for hepatitis C virus (HCV) infection has evolved over time, and direct-acting antivirals (DAA) have revolutionized HCV therapy. OBJECTIVES: To (a) assess early treatment discontinuation and (b) identify predictors of early discontinuation in a cohort of patients receiving second-generation DAAs. METHODS: We identified HCV patients newly prescribed simeprevir/sofosbuvir (SIM/SOF), ledipasvir/sofosbuvir (LDV/SOF),...
Paper Details
Title
Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World
Published Date
Jun 1, 2019
Volume
25
Issue
6
Pages
697 - 704
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History